Social Pulse: Avanir Pharmaceuticals Inc (AVNR.OQ)
AVNR.OQ on NASDAQ Stock Exchange Global Select Market
4.83USD
1:35pm EDT
4.83USD
1:35pm EDT
Price Change (% chg)
$0.07 (+1.47%)
$0.07 (+1.47%)
Prev Close
$4.76
$4.76
Open
$4.74
$4.74
Day's High
$4.93
$4.93
Day's Low
$4.72
$4.72
Volume
386,545
386,545
Avg. Vol
447,082
447,082
52-wk High
$5.09
$5.09
52-wk Low
$2.07
$2.07
- Coming Soon: Avanir Pharmaceuticals Earnings
- Biotech Stock Mailbag: Apricus, Avanir
- Why Buy Avanir Pharmaceuticals
- Avanir Pharmaceuticals and OptiNose Announce Development and Commercialization Agreement for a New Fast-Acting Investigational Product for the Treatment of Acute Migraine (Transcript)
- Amarantus Teams With Becton, Dickinson For LymPro Development, Seeking PD-LID Candidate
- 5 of Last Week's Biggest Winners
Press Releases
- Avanir Pharmaceuticals Reports Fiscal 2012 Fourth Quarter And Year-End Financial And Business Results
- Avanir Pharmaceuticals Announces Date of Fiscal 2012 Fourth Quarter and Year End Financial Results and Conference Call
- Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
- Avanir Pharmaceuticals To Present At 24th Annual Piper Jaffray Healthcare Conference
- The Michael J. Fox Foundation Awards Grant To Support Avanir Pharmaceuticals' Clinical Study Of AVP-923 For Levodopa Induced Dyskinesia In Parkinson's Disease

